Gilead says remdesivir shows improvement in COVID-19 patients when used early

9:26am PDT - April 29th, 2020    remdesivir - Reuters

Gilead Sciences Inc on Wednesday said its experimental antiviral drug remdesivir helped improve outcomes for patients with COVID-19, and provided data suggesting it worked better when given earlier in the course of infection.